Cancer treatment developer CG Oncology files for IPO

Open A/C With Alice Blue

Most Popular FnO Broker

Flat ₹15 Per Trade

Bladder cancer treatment developer CG Oncology has filed an initial public offering with the Securities and Exchange Commission.

Open Demat A/C With Zerodha

Free Eq Delivery & MF

Flat ₹20 Per Trade

Open Account

The Irvine, Calif.-based biopharmaceutical company is developing a potential treatment for bladder cancer patients unresponsive to Bacillus Calmette-Guerin antibiotic therapy.

CG Oncology does not say…

section>Bladder cancer treatment developer CG Oncology has filed an initial public offering with the Securities and Exchange Commission.

The Irvine, Calif.-based biopharmaceutical company is developing a potential treatment for bladder cancer patients unresponsive to Bacillus Calmette-Guerin antibiotic therapy.

CG Oncology did not say how many shares it plans to offer or provide an estimated price range. The company plans to use the funds primarily for operational support.

The company used to list its shares on the Nasdaq Global market under the ticker CGON.

Morgan Stanley, Goldman Sachs & Co., Cantor and Lifesci Capital are acting as underwriters for the offering.

The views and investment tips expressed by experts on kunjcapital.com are their own and not those of the website or its management. Kunjcapital.com advises users to check with certified experts before making any investment decisions. *Services related to Advisory on Kunjcapital.com are not running by kunjcapital.com and they are proposed services, Sebi Registration Awaited.